Clinical Trial Detail

NCT ID NCT02619864
Title mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications

glioblastoma multiforme

Therapies

Vistusertib

Age Groups: adult

No variant requirements are available.